Candriam S.C.A. Invests $18.44 Million in UiPath, Inc. $PATH

Key Points

• Candriam S.C.A. has acquired a new stake in UiPath, Inc., purchasing approximately 1.79 million shares valued at around $18.44 million, representing about 0.32% of the company.
• Several institutional investors, including Invesco Ltd. and Raymond James Financial Inc., have also increased or established their stakes in UiPath during the fourth quarter.
• UiPath reported a net revenue of $356.62 million for the quarter, surpassing analyst expectations, with a current average stock rating of "Hold" from equities analysts.

Candriam S.C.A. bought a new stake in shares of UiPath, Inc. (NYSE:PATH - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,790,313 shares of the company's stock, valued at approximately $18,440,000. Candriam S.C.A. owned about 0.32% of UiPath at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in PATH. Versant Capital Management Inc lifted its stake in UiPath by 198.6% during the first quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock valued at $31,000 after purchasing an additional 1,970 shares during the last quarter. CX Institutional acquired a new stake in UiPath during the first quarter valued at approximately $36,000. Brooklyn Investment Group lifted its stake in UiPath by 314.3% during the first quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock valued at $46,000 after purchasing an additional 3,420 shares during the last quarter. True Wealth Design LLC lifted its stake in UiPath by 18.4% during the fourth quarter. True Wealth Design LLC now owns 5,163 shares of the company's stock valued at $66,000 after purchasing an additional 801 shares during the last quarter. Finally, National Bank of Canada FI acquired a new stake in UiPath during the first quarter valued at approximately $72,000. 62.50% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Needham & Company LLC reissued a "hold" rating on shares of UiPath in a research note on Friday, May 30th. DA Davidson upgraded shares of UiPath to a "hold" rating in a research report on Tuesday, July 22nd. Zacks Research upgraded shares of UiPath to a "hold" rating in a research report on Friday, August 8th. Wall Street Zen downgraded shares of UiPath from a "strong-buy" rating to a "buy" rating in a research report on Sunday, August 3rd. Finally, Barclays restated an "equal weight" rating on shares of UiPath in a research report on Friday, May 30th. Two research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $13.83.

Insiders Place Their Bets

In other UiPath news, CEO Daniel Dines sold 45,000 shares of the stock in a transaction on Wednesday, July 16th. The shares were sold at an average price of $12.43, for a total value of $559,350.00. Following the completion of the sale, the chief executive officer directly owned 5,058,376 shares of the company's stock, valued at $62,875,613.68. This represents a 0.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Ashim Gupta sold 56,322 shares of the stock in a transaction on Wednesday, July 2nd. The shares were sold at an average price of $12.72, for a total transaction of $716,415.84. Following the completion of the sale, the chief financial officer directly owned 859,991 shares of the company's stock, valued at approximately $10,939,085.52. This trade represents a 6.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 831,310 shares of company stock worth $10,428,922 over the last quarter. 23.19% of the stock is currently owned by company insiders.

UiPath Price Performance

UiPath stock traded up $0.2450 during trading hours on Friday, hitting $11.1350. The company had a trading volume of 10,204,070 shares, compared to its average volume of 12,036,690. UiPath, Inc. has a fifty-two week low of $9.38 and a fifty-two week high of $15.93. The firm's fifty day moving average is $12.04 and its 200-day moving average is $12.06. The firm has a market capitalization of $5.96 billion, a P/E ratio of -92.78, a price-to-earnings-growth ratio of 14.63 and a beta of 1.03.

UiPath (NYSE:PATH - Get Free Report) last posted its earnings results on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The business had revenue of $356.62 million for the quarter, compared to analyst estimates of $332.17 million. During the same period last year, the business posted $0.13 EPS. UiPath's revenue was up 6.4% compared to the same quarter last year. UiPath has set its Q2 2026 guidance at EPS. FY 2026 guidance at EPS. Analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.